Purchase Order 75N95019P00069
Award Date 12/14/18
Potential Completion Date 12/13/21
Potential Value $43K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Carlsbad, CA 92008, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Institute on Drug Abuse awarded a purchase order to Life Technologies Corporation for $16,990.88 on July 30, 2019. The order carries no set-aside designation and has a firm fixed price structure. Performance takes place in Carlsbad, California. The ultimate completion date is July 31, 2022. The order is part of the FY26 UDO Initiative.</p>
- The National Institute on Drug Abuse issued a purchase order to Life Technologies Corporation on September 21, 2022, for $57,524.81 under a firm fixed-price arrangement. Performance is located in Carlsbad, California. The order was issued in response to a solicitation posted September 7, 2022, with a due date of September 13, 2022. Ultimate completion is scheduled for October 30, 2022. No set-aside was applied. The award covers commercial scientific equipment, reagents, consumables, or related...
- <p>The National Institute on Drug Abuse issued a purchase order to Phenomenex, Inc. on September 8, 2021, valued at $10,591.45 for administrative de-obligation of unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), with ultimate completion on October 8, 2021. Place of performance is Baltimore, Maryland. The order is firm fixed price with no set-aside.</p>
- <p>The National Institute on Drug Abuse issued a purchase order to Life Technologies Corporation for $21,809.00 on September 27, 2021, for GIBCO medium and supplements to restock cell culture inventory. Performance occurs at Grand Island, New York, with delivery required 14 days after order date and ultimate completion by February 24, 2022. The order is firm fixed price, no set-aside, and obligates expiring fiscal year 2021 funds in accordance with 31 U.S.C. Section 1552(a).</p>
- The National Institute on Drug Abuse awarded a purchase order to Quanterix Corporation for $46,936.00 on July 1, 2021, to administrate de-obligation of unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), with final completion by September 30, 2023. Work is performed in Billerica, Massachusetts. The purchase order carries no set-aside designation and is priced on a firm fixed-price basis. The period of performance covers July 1, 2021 through June 30,...
- <p>The National Institute on Drug Abuse awarded a purchase order to Qiagen, LLC on September 16, 2021, with a firm fixed price ceiling value of $24,943.02 to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a). Place of performance is Baltimore, Maryland. The order's ultimate completion date was October 16, 2021.</p>
- The National Institute on Drug Abuse issued a purchase order to Life Technologies Corporation valued at $16,804.50 on September 14, 2021, for cell culture media including STEMFLEX Medium Combo Kits, Essential 8 Medium Kits, and STEMPRO NSC SFM Kits. Performance occurs in Carlsbad, California. The order was issued to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) prior to the September 30, 2026 close of the period of availability....
- The National Institute on Drug Abuse issued a purchase order to David Kopf Instruments valued at $12,835.09 on September 6, 2021, to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability. No set-aside was used. Place of performance is Baltimore, Maryland. The order carries a firm fixed price and an ultimate completion date of October 4, 2021.
- The National Institute on Drug Abuse issued a purchase order to Government Scientific Source Inc., a small business, for $9,679.68 on February 18, 2021. The order was firm fixed price with no set-aside designation. Place of performance was Baltimore, Maryland. The purchase order was issued to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability...
- The National Institute on Drug Abuse awarded a purchase order to Eurofins Discoverx LLC for $24,293.10 in testing compounds on September 17, 2021, with ultimate completion on September 17, 2022. The order was issued as a firm fixed price acquisition to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), in preparation for the September 30, 2026 closing of fund availability. Work is performed in Fremont, California. No set-aside was used.